Search research articles
Contact Us
Filters
Showing results (251-260 of 22,551) with videos related to
Page
of 2,256
Sort By:
Oncogene
|
March 4, 1998
The N-terminal 178-amino-acid domain only of the SV40 large T antigen acts as a transforming suppressor of the HER-2/neu oncogene
M C Kao, G Y Liu, T C Chuang, et al.
Oncogene
|
May 20, 1998
Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G
G Posern, J Zheng, B S Knudsen, et al.
Oncogene
|
May 20, 1998
Insulin-like growth factor-1 stimulates rat prolactin gene expression by a Ras, ETS and phosphatidylinositol 3-kinase dependent mechanism
A I Castillo, R M Tolon, A Aranda
Oncogene
|
May 20, 1998
Expression of the v-Src oncoprotein in fibroblasts disrupts normal regulation of the CDK inhibitor p27 and inhibits quiescence
D Johnson, M C Frame, J A Wyke
Oncogene
|
June 10, 1998
Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation
I Bongarzone, E Vigano, L Alberti, et al.
Oncogene
|
June 10, 1998
Inhibition of mSOS-activity by binding of phosphatidylinositol 4,5-P2 to the mSOS pleckstrin homology domain
A B Jefferson, A Klippel, L T Williams
Oncogene
|
June 10, 1998
v-fps causes transformation by inducing tyrosine phosphorylation and activation of the PDGFbeta receptor
D H Anderson, P M Ismail
Oncogene
|
June 10, 1998
Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation
J Houldsworth, H Xiao, V V Murty, et al.
Oncogene
|
June 10, 1998
The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4
Y I Lee, S Lee, Y Lee, et al.
Oncogene
|
June 10, 1998
A role of the tuberous sclerosis gene-2 product during neuronal differentiation
T Soucek, G Hölzl, G Bernaschek, et al.
Page
of 2,256
Search research articles
Search
Showing results (251-260 of 22,551) with videos related to
Sort By:
Page
of 2,256
Oncogene
|
March 4, 1998
The N-terminal 178-amino-acid domain only of the SV40 large T antigen acts as a transforming suppressor of the HER-2/neu oncogene
M C Kao, G Y Liu, T C Chuang, et al.
Oncogene
|
May 20, 1998
Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G
G Posern, J Zheng, B S Knudsen, et al.
Oncogene
|
May 20, 1998
Insulin-like growth factor-1 stimulates rat prolactin gene expression by a Ras, ETS and phosphatidylinositol 3-kinase dependent mechanism
A I Castillo, R M Tolon, A Aranda
Oncogene
|
May 20, 1998
Expression of the v-Src oncoprotein in fibroblasts disrupts normal regulation of the CDK inhibitor p27 and inhibits quiescence
D Johnson, M C Frame, J A Wyke
Oncogene
|
June 10, 1998
Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation
I Bongarzone, E Vigano, L Alberti, et al.
Oncogene
|
June 10, 1998
Inhibition of mSOS-activity by binding of phosphatidylinositol 4,5-P2 to the mSOS pleckstrin homology domain
A B Jefferson, A Klippel, L T Williams
Oncogene
|
June 10, 1998
v-fps causes transformation by inducing tyrosine phosphorylation and activation of the PDGFbeta receptor
D H Anderson, P M Ismail
Oncogene
|
June 10, 1998
Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation
J Houldsworth, H Xiao, V V Murty, et al.
Oncogene
|
June 10, 1998
The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4
Y I Lee, S Lee, Y Lee, et al.
Oncogene
|
June 10, 1998
A role of the tuberous sclerosis gene-2 product during neuronal differentiation
T Soucek, G Hölzl, G Bernaschek, et al.
Page
of 2,256